This inventor holds 1 USPTO granted patent. Top assignee: Korea Center for Disease Control and Prevention. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovator in Cancer Research: Jee Eun Rhee
Introduction
Jee Eun Rhee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of cancer research, particularly in the development of methods for screening anticancer compounds. Her work is vital in the fight against uterine cervical cancer, a prevalent health issue.
Latest Patents
Jee Eun Rhee holds a patent for a "Cell line stably expressing mutated oncoprotein E6 and method of screening anticancer compound of uterine cervical cancer using the same." This patent discloses a cell line that expresses a specific protein and outlines a method for screening anticancer compounds. The stable cell line expressing oncoprotein E6 from a human papillomavirus type 16 variant strain is utilized to assess differences in the expression of tumor suppressor genes, such as p53. This innovative approach aids in identifying potential anticancer agents for uterine cervical cancer.
Career Highlights
Jee Eun Rhee is affiliated with the Korea Center for Disease Control and Prevention, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and prevention.
Collaborations
She collaborates with notable colleagues, including Sung Soon Kim and Dae Ho Jang, to advance her research initiatives. These collaborations enhance the scope and effectiveness of her work in cancer research.
Conclusion
Jee Eun Rhee's contributions to cancer research through her innovative patent and collaborative efforts position her as a key figure in the ongoing battle against uterine cervical cancer. Her work exemplifies the importance of innovation in medical research and its potential to save lives.